Stockreport

Alzamend Neuro Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]

Alzamend Neuro, Inc.  (ALZN) 
PDF focused on developing novel products for the treatment of Alzheimer's disease (" Alzheimer's "), bipolar disorder (" BD "), major depressive disorder (" MDD ") and post- [Read more]